WHOCC
Postal address:
Norwegian Institute of Public Health
WHO Collaborating Centre for Drug Statistics Methodology
Postboks 222 Skøyen
0213 Oslo
Norway

Visiting/delivery address:
Myrens verksted 6H
0473 Oslo
Norway

Tel:  +47 21 07 81 60
E-mail:
 
Copyright/Disclaimer

New ATCvet 5th levels 2025

 Updates included in the ATCvet Index valid from 2025.

ATCvet codeATCvet level name
QV10XA04iodine (131I) apamistamab
QV09IX18flotufolastat (18F)
QV07AQ02ractopamin
QV07AQ01lubabegron
QV04CX12xenon
QS01XA33diquafosol
QS01XA32avacincaptad pegol
QS01EE52latanoprost and dorzolamide
QS01EA55brimonidine and ripasudil
QS01AX25lotilaner
QR07AX33deutivacaftor, tezacaftor and vanzacaftor
QN07XX25omaveloxolone
QN07XX24trofinetide
QN07BB06ondelopran
QN06AX31zuranolone
QN02CD08zavegepant
QN02BG93izenivetmab
QN02BG92relfovetmab
QM01AE20pelubiprofen
QM01AE19loxoprofen
QL04AX10tegomil fumarate
QL04AJ11pozelimab
QL04AJ10vilobelimab
QL04AG17seniprutug
QL04AC26goflikicept
QL04AA60remibrutinib
QL03AX24mavorixafor
QL03AX23motixafortide
QL01XY04bifikafusp alfa and onfekafusp alfa
QL01XX86calaspargase pegol
QL01XX85idroxioleic acid
QL01XX84pelabresib
QL01XX83para-toluenesulfonamide
QL01XX82darinaparsin
QL01XX81nirogacestat
QL01XM04vorasidenib
QL01XM03olutasidenib
QL01XL12obecabtagene autoleucel
QL01XH07resminostat
QL01XH06tucidinostat
QL01FX36patritumab deruxtecan
QL01FX35datopotamab deruxtecan
QL01FX34odronextamab
QL01FX33tarlatamab
QL01FX32elranatamab
QL01FX31zolbetuximab
QL01FD07zanidatamab
QL01EX28repotrectinib
QL01EL06tirabrutinib
QL01EE05mirdametinib
QL01DC05utidelone
QJ05AX33labuvirtide
QJ05AX32riamilovir
QJ05AR29emtricitabine, tenofovir alafenamide and dolutegravir
QJ05AP14narlaprevir
QJ05AG07elsulfavirine
QJ04AM12rifampicin, pyrazinamide, isoniazid and levofloxacin
QJ04AM11rifabutin, pyrazinamide and protionamide
QJ04AM10pyrazinamide, ethambutol, protionamide and lomefloxacin
QJ04AM09pyrazinamide, ethambutol, isoniazid and lomefloxacin
QJ04AC02ftivazide
QJ01XX13gepotidacin
QJ01RA19tetracycline and nystatin
QJ01RA18ofloxacin and tinidazole
QJ01RA17ofloxacin and nitazoxanide
QJ01DF51aztreonam and beta-lactamase inhibitor
QI02AH01live bovine rhinotracheitis virus (IBR) + live bovine respiratory syncytial virus (BRSV) + inactivated bovine viral diarrhea (BVD) + inactivated bovine parainfluenza virus
QI01AD20avian herpes virus (marek's disease) + avian infectious laryngotracheitis virus + avian infectious bursal disease virus (gumboro) disease + newcastle disease virus
/paramyxovirus
QC10BX22rosuvastatin and nebivolol
QC10BA13pitavastatin and ezetimibe
QC09XX01sparsentan
QC08DA03etripamil
QC02KX06sotatercept
QC01EB25acoramidis
QB06AC08sebetralstat
QB06AC07garadacimab
QB03XA10efepoetin alfa
QB03XA09molidustat
QB02BX11marstacimab
QB02BD17fidanacogene elaparvovec
QA16AX25nedosiran
QA16AX24govorestat
QA10XX02donislecel
QA10BK09enavogliflozin
QA10BD30gemigliptin and dapagliflozin
QA05AX07seladelpar
QA02BC11ilaprazole
QA02BC10fexuprazan

Last updated: 2024-12-16